Calcitriol Regresses Cardiac Hypertrophy and QT Dispersion in Secondary Hyperparathyroidism on Hemodialysis

Publisher： Karger

E-ISSN： 1660-2110|102|1|c21-c29

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.102, Iss.1, 2005-09, pp. : c21-c29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cinacalcet Improves Endothelial Dysfunction and Cardiac Hypertrophy in Patients on Hemodialysis with Secondary Hyperparathyroidism

By  

Nephron Clin Pract, Vol. 122, Iss. 1-2, 2013-03 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Effects of Pamidronate and Calcitriol on the Set Point of the Parathyroid Gland in Postmenopausal Hemodialysis Patients with Secondary Hyperparathyroidism

By  

Nephron Clin Pract, Vol. 122, Iss. 3-4, 2013-04 ,pp. : 93-101

Karger

Access to resources Recommend Favorite

Efficacy of Intravenous Alfacalcidol in the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis

By  

Nephron Clin Pract, Vol. 108, Iss. 2, 2008-02 ,pp. : c141-c147

Karger

Access to resources Recommend Favorite

Comparative Effectiveness of Paricalcitol versus Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

By  

Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. : c151-c159

Karger

Access to resources Recommend Favorite

Comparison of Paricalcitol With Maxacalcitol Injection in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 3, 2015-06 ,pp. : 225-234

John Wiley & Sons Inc

Access to resources Recommend Favorite